Table 2.
Screening sensitivity according to screening modality and age at diagnosis
| Sensitivity | All breast cancers n = 85 | Breast cancers diagnosed before age 40 N = 17 (20.0%) |
Breast cancers diagnosed at age ≥ 40 years n = 68 (80.0%) |
p |
|---|---|---|---|---|
| Combined screening | ||||
| All breast cancers | 95.2% (81/85) | 94.1% (16/17) | 95.6% (65/68) | 1.000 |
| DCIS | 100% (23/23) | 100% (6/6) | 100% (17/17) | 1.000 |
| Invasive breast cancer | 93.5% (58/62) | 90.1% (10/11) | 94.1% (48/51) | 1.000 |
| MR screening | ||||
| All breast cancers | 85.8% (73/85) | 88.2% (15/17) | 85.3% (58/68) | 1.000 |
| DCIS | 73.9% (17/23) | 83.3% (5/6) | 70.6% (12/17) | 1.000 |
| Invasive breast cancer | 90.3% (56/62) | 90,9% (10/11) | 90.1% (46/51) | 1.000 |
| X screening | ||||
| All breast cancers | 49,4% (42/85) | 47.1% (8/17) | 50.0% (34/68) | 1.000 |
| DCIS | 65.2% (15/23) | 50.0% (3/6) | 70.6% (12/17) | 0.621 |
| Invasive breast cancer | 43.5% (27/62) | 45.4% (5/11) | 43.1% (22/51) | 1.000 |